0001140361-13-045018.txt : 20131205 0001140361-13-045018.hdr.sgml : 20131205 20131205152209 ACCESSION NUMBER: 0001140361-13-045018 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131205 DATE AS OF CHANGE: 20131205 EFFECTIVENESS DATE: 20131205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Roka BioScience, Inc. CENTRAL INDEX KEY: 0001472343 IRS NUMBER: 270881542 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-207477 FILM NUMBER: 131259781 BUSINESS ADDRESS: STREET 1: 10210 GENETIC CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 212-739-6400 MAIL ADDRESS: STREET 1: 10210 GENETIC CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0707 D LIVE 0001472343 Roka BioScience, Inc. 20 Independence Boulevard 4th Floor Warren NJ NEW JERSEY 07059 908-605-4700 DELAWARE None None Corporation true 2009 Steven Sobieski c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Executive Officer Chief Financial Officer and Treasurer Paul Thomas c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Executive Officer Director President, Chief Executive Officer and Secretary Jim Barret, PhD c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Josh Bilenker, MD c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Jonathan Silverstein c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Fred Cohen c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Michael P. Doyle c/o Roka BioScience, Inc. 20 Independence Boulevard, 4th Floor Warren NJ NEW JERSEY 07059 Director Biotechnology Decline to Disclose 06b false 2013-11-20 false true true Series E Preferred Stock convertible into Series A Common Stock false 0 16996657 16996657 0 false 5 0 0 0 true A portion of the proceeds may be used for general corporate purposes. Salaries and/or director fees may be paid to certain related persons in Item 3. The amount of such fees cannot be determined as this time. false Roka BioScience, Inc. /s/ Paul Thomas Paul Thomas President, Chief Executive Officer and Secretary 2013-12-04